Expression of elastase and fibrin in venous leg ulcer biopsies: a pilot study of pentoxifylline versus placebo.
The pathogenesis of venous leg ulcers is based on the leakage of fibrinogen leading to a pericapillary fibrin cuff and plugging of capillaries by white blood cells. On the basis of a previous work, we had assumed that the key event in the pathogenesis of venous leg ulcers is related to inflammation generated by activated white blood cells that accumulate under unrelieved blood pressure, because in ulcer biopsies we had detected the presence of tumor necrosis factor-alpha (TNF-alpha) in intracapillary monocytes, elastase in the polymorphonuclear leukocytes near the vessels, and a pericapillary undegraded fibrin cuff causing a diffusion barrier to oxygen. This concept was developed because TNF-alpha synthesized by activated monocytes is responsible for many deleterious effects. It has a potent mitogenic effect on fibroblasts, leading to new collagen deposition and angiogenesis, it induces an increase in collagenase production, it acts through upregulation of an intracellular adhesion molecule (ICAM-1), leading to leukocyte sequestration and consequently a release of toxic metabolites by the polymorphonuclear cells, an early step in chronic inflammation, it activates the coagulation pathway via a marked increase in monocyte-associated tissue factor (TF) procoagulant activity, and it inhibits fibrinolysis by promoting the release of PAI-1, contributing to undegraded fibrin deposition. Therefore, we were interested in evaluating, in patients with venous leg ulcers, the effect of pentoxifylline administered at 1,200 mg daily (versus placebo) for 2-months, as this drug induces a decrease in TNF-alpha synthesis and also blocks its activity. This pilot assay was performed in blind. Evolution of several parameters in ulcer biopsies are analyzed: TNF-alpha, intact fibrin, fibrin degradation products, ICAM-1, TF, and elastase. Pentoxifylline administration induced a decrease of local elastase and of fibrin deposit. These results support the hypothesis that accumulation of activated leukocytes is the key event in venous leg ulcers.
Mirshahi
S
S
Laboratoire Sainte Marie, Hôtel Dieu, Paris, France.
Soria
J
J
Mirshahi
M
M
Soria
C
C
Lenoble
M
M
Vasmant
D
D
Cambazard
F
F
Claudy
A
A
D000911:Antibodies, Monoclonal; D005337:Fibrin / Q000096:biosynthesis*; D006801:Humans; D010196:Pancreatic Elastase / Q000096:biosynthesis*; D016612:Paraffin Embedding; D010431:Pentoxifylline / Q000627:therapeutic use*; D010865:Pilot Projects; D014647:Varicose Ulcer / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D014665:Vasodilator Agents; D005337:Fibrin; D010196:Pancreatic Elastase; D010431:Pentoxifylline